Targeted investments with significant strategic value, mutual financial benefit and a faster path to market
We invest globally in aesthetic healthcare companies who are pursuing innovative, breakthrough science. Our primary goal is to link our expertise with advanced ideas and technologies from emerging companies or academic institutions.
Through the Merz Corporate Venture Capital Initiative, we offer up initial funding in the early stages of development of a company or technology and are committed to further investments in pace with the company’s progress. This could be alone, or in conjunction with other venture capital and investment funds.
In addition to financial backing, we provide extensive experience and a global network that allows our partners to work closely with management teams and fellow investors to create significant value.